CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-14 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −33 | 97 | ||
| 2026-03-14 | Rodriguez Javier See Remarks | Option exercise | +33 | 6,828 | ||
| 2026-03-14 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units | −33 | 97 | ||
| 2026-03-14 | Yocca Frank Chief Scientific Officer | Option exercise | +33 | 6,485 | ||
| 2026-03-14 | Yocca Frank Chief Scientific Officer | Option exercise · Restricted Stock Units | −33 | 97 | ||
| 2026-01-09 | Laumas Sandeep Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-01-09 | Patni Rajiv Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-01-09 | MUELLER PETER Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-01-09 | Votruba Michal Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-01-09 | MILLER MICHAEL PATRICK Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-01-09 | Bray June Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-01-09 | MACK DAVID J. Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2026-01-01 | Yocca Frank Chief Scientific Officer | Grant or award · Restricted Stock Units | +70,000 | 70,282 | ||
| 2026-01-01 | Steinhart Richard I Chief Financial Officer | Grant or award · Restricted Stock Units | +70,000 | 70,282 | ||
| 2026-01-01 | Mehta Vimal CEO and President | Grant or award · Restricted Stock Units | +199,032 | 200,783 | ||
| 2026-01-01 | Rodriguez Javier See Remarks | Grant or award · Restricted Stock Units | +70,000 | 70,282 | ||
| 2025-12-15 | Mehta Vimal CEO and President | Option exercise | +219 | 20,876 | ||
| 2025-12-15 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units | −219 | 1,751 | ||
| 2025-12-15 | Steinhart Richard I Chief Financial Officer | Option exercise | +35 | 6,577 | ||
| 2025-12-15 | Steinhart Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −35 | 282 |
Page 3 of 27 · 521 trades